Markets.com Logo
markets.com

DRMA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    5.1924$
  • Previous Close
    5.3558$
  • 52 Week Change
    19.81$
  • Day Range
    -0.16$
  • 52 Week High/Low
    5.09$ - 24.9$
  • Dividend Per Share
    --
  • Market cap
    3 451 K$
  • EPS
    -1.66
  • Beta
    0.558
  • Volume
    --

About

DRMA.US is the ticker symbol for Dermata Therapeutics, Inc., a clinical-stage biotechnology company focused on developing and commercializing innovative, differentiated, and proprietary medical dermatology products. Their primary focus is on addressing unmet needs in common skin conditions like acne, rosacea, and aesthetic skin conditions.
markets.com

Factors

Company Performance: Revenue, earnings, and profit margins directly influence investor confidence and stock valuation.

Industry Trends: The overall health and growth prospects of the media and entertainment sector impact DRMA.US, affecting investor sentiment.

Regulatory Environment: Changes in media regulations or content restrictions can significantly affect the business operations and perceived value of DRMA.US.

Competition: Actions by competitors, such as new service launches or pricing strategies, can influence DRMA.US's market share and profitability.

Economic Conditions: Broader economic factors, including interest rates, inflation, and consumer spending, affect overall market sentiment and investment decisions regarding DRMA.US.

Technological Advancements: New technologies, such as streaming platforms or AI-driven content creation, can disrupt the media landscape and impact DRMA.US's competitive position.

People Also Watch

Latest news

Gold Price Today, August 18, 2026: XAU/USD Rises Above $4,420 as Fed Hike Bets Fade

Gold Price Today, August 18, 2026: XAU/USD Rises Above $4,420 as Fed Hike Bets Fade

Julian Parker|--
Brent Tops $91 as Iran Tensions Revive Hormuz Supply Fears

Brent Tops $91 as Iran Tensions Revive Hormuz Supply Fears

Julian Parker|--
Anthropic Revenue Run Rate Reportedly Exceeds $65 Billion as IPO Valuation Debate Intensifies

Anthropic Revenue Run Rate Reportedly Exceeds $65 Billion as IPO Valuation Debate Intensifies

Julian Parker|--

Latest Education Articles

What Is Overtrading? Signs & How to Avoid It

What Is Overtrading? Signs & How to Avoid It

Julian Parker|--
Active vs Passive Investing: What’s the difference?

Active vs Passive Investing: What’s the difference?

Julian Parker|--
CFD Forex Trading in the UAE: What It Means and How It Works

CFD Forex Trading in the UAE: What It Means and How It Works

Daniel Carter|--
Recommended Topics
markets.com